Plans to recall the Neupro (rotigotine) patch are bringing up questions about what to do with remaining pharmacy inventory

Plans to recall the Neupro (rotigotine) patch are bringing up questions about what to do with remaining pharmacy inventory.

Neupro (rotigotine) was heralded as a big advance last year as the first patch for Parkinson's disease. It's similar to Mirapex (pramipexole) and Requip (ropinirole).

Now the patches are being recalled because of problems with crystals forming...which could decrease drug delivery.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote